Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus

OBJECTIVE: The severity and disease course of cutaneous lupus erythematosus (CLE) are highly variable. Consequently, outcome measures for CLE clinical improvement are heterogeneous, complicating treatment decisions and therapeutic development. This study characterises CLE outcome measures and identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanes, Benjamin A, Zhu, Jane L, Chong, Benjamin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cutaneous Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008708/
https://www.ncbi.nlm.nih.gov/pubmed/32095249
http://dx.doi.org/10.1136/lupus-2019-000364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008708/
https://www.ncbi.nlm.nih.gov/pubmed/32095249
http://dx.doi.org/10.1136/lupus-2019-000364

Ejemplares similares